Diuretic MAG3 scintirenography in children with HIV nephropathy: Diffuse parenchymal dysfunction

George N Sfakianakis, Antonio J. Carmona, Amita Sharma, Jose Strauss, Mike Georgiou, Gaston E Zilleruelo, Carolyn Abitbol, Brenda S. Montane

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

HIV nephropathy (HIVN) is prevalent in 15%-56% of HIV-infected children and induces mild to severe progressive nephropathy. Methods: A total of 33 renal diuretic scintirenographic studies with 99mTc- mercaptoacetyltriglycine (MAG3) were reviewed and analyzed from 23 HIV pediatric patients, 21 of whom had HIVN with varying degrees of renal impairment. Results were compared with 10 studies of control patients of matching ages. Visual interpretation of images and renograms as well as semiquatitative analyses were performed. Variables compared were size of kidneys, time of peak and one-half peak activities, residual (or retained) cortical activity at 20 min, ratio of cortical activity at 2.5-20 min, and ratio of kidney activity to kidney plus background activity at 2 min. The results of MAG3 renal studies were also compared with laboratory data pertaining to creatinine clearance in all patients and with sonography in 17 patients. Results: In most patients with HIVN (18/21), the kidneys were larger than normal, with a diffuse parenchymal dysfunction (decreased uptake, slow processing, and increased retention of activity) and flat renograms, findings similar to those observed in other diffuse parenchymal diseases. In all patients with HIVN, semiquantitative analysis (paired t test) showed statistical significant differences from control patients for all variables. On ANOVA, a statistically significant correlation was found between most scintigraphic parameters and the severity of renal impairment. Of the 17 concurrent sonographic studies in HIVN patients, 7 showed no abnormalities, whereas the results of scintigraphy were abnormal. Conclusion: Diuretic MAG3 scintirenography shows nonspecific diffuse parenchymal dysfunction in pediatric patients with HIVN. Such dysfunction may provide corroborative evidence of HIVN and should be recognized when the test is performed for standard indications. Further work is necessary to prove that the test has indeed the high sensitivity and good correlation with the severity of HIVN suggested in this population; the test may be useful to follow up the progression of disease and the effect of treatment.

Original languageEnglish
Pages (from-to)1037-1042
Number of pages6
JournalJournal of Nuclear Medicine
Volume41
Issue number6
StatePublished - Jun 1 2000

Fingerprint

Diuretics
HIV
Kidney
Technetium Tc 99m Mertiatide
Pediatrics
Radionuclide Imaging
Disease Progression
Ultrasonography
Creatinine
Analysis of Variance
Cohort Studies

Keywords

  • Tc-mercaptoacetyltriglycine
  • AIDS
  • HIV nephropathy
  • Pediatrics
  • Scintirenography

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Sfakianakis, G. N., Carmona, A. J., Sharma, A., Strauss, J., Georgiou, M., Zilleruelo, G. E., ... Montane, B. S. (2000). Diuretic MAG3 scintirenography in children with HIV nephropathy: Diffuse parenchymal dysfunction. Journal of Nuclear Medicine, 41(6), 1037-1042.

Diuretic MAG3 scintirenography in children with HIV nephropathy : Diffuse parenchymal dysfunction. / Sfakianakis, George N; Carmona, Antonio J.; Sharma, Amita; Strauss, Jose; Georgiou, Mike; Zilleruelo, Gaston E; Abitbol, Carolyn; Montane, Brenda S.

In: Journal of Nuclear Medicine, Vol. 41, No. 6, 01.06.2000, p. 1037-1042.

Research output: Contribution to journalArticle

Sfakianakis, GN, Carmona, AJ, Sharma, A, Strauss, J, Georgiou, M, Zilleruelo, GE, Abitbol, C & Montane, BS 2000, 'Diuretic MAG3 scintirenography in children with HIV nephropathy: Diffuse parenchymal dysfunction', Journal of Nuclear Medicine, vol. 41, no. 6, pp. 1037-1042.
Sfakianakis GN, Carmona AJ, Sharma A, Strauss J, Georgiou M, Zilleruelo GE et al. Diuretic MAG3 scintirenography in children with HIV nephropathy: Diffuse parenchymal dysfunction. Journal of Nuclear Medicine. 2000 Jun 1;41(6):1037-1042.
Sfakianakis, George N ; Carmona, Antonio J. ; Sharma, Amita ; Strauss, Jose ; Georgiou, Mike ; Zilleruelo, Gaston E ; Abitbol, Carolyn ; Montane, Brenda S. / Diuretic MAG3 scintirenography in children with HIV nephropathy : Diffuse parenchymal dysfunction. In: Journal of Nuclear Medicine. 2000 ; Vol. 41, No. 6. pp. 1037-1042.
@article{a5414f49ddbf4ba0a6b5fc67e7096aa9,
title = "Diuretic MAG3 scintirenography in children with HIV nephropathy: Diffuse parenchymal dysfunction",
abstract = "HIV nephropathy (HIVN) is prevalent in 15{\%}-56{\%} of HIV-infected children and induces mild to severe progressive nephropathy. Methods: A total of 33 renal diuretic scintirenographic studies with 99mTc- mercaptoacetyltriglycine (MAG3) were reviewed and analyzed from 23 HIV pediatric patients, 21 of whom had HIVN with varying degrees of renal impairment. Results were compared with 10 studies of control patients of matching ages. Visual interpretation of images and renograms as well as semiquatitative analyses were performed. Variables compared were size of kidneys, time of peak and one-half peak activities, residual (or retained) cortical activity at 20 min, ratio of cortical activity at 2.5-20 min, and ratio of kidney activity to kidney plus background activity at 2 min. The results of MAG3 renal studies were also compared with laboratory data pertaining to creatinine clearance in all patients and with sonography in 17 patients. Results: In most patients with HIVN (18/21), the kidneys were larger than normal, with a diffuse parenchymal dysfunction (decreased uptake, slow processing, and increased retention of activity) and flat renograms, findings similar to those observed in other diffuse parenchymal diseases. In all patients with HIVN, semiquantitative analysis (paired t test) showed statistical significant differences from control patients for all variables. On ANOVA, a statistically significant correlation was found between most scintigraphic parameters and the severity of renal impairment. Of the 17 concurrent sonographic studies in HIVN patients, 7 showed no abnormalities, whereas the results of scintigraphy were abnormal. Conclusion: Diuretic MAG3 scintirenography shows nonspecific diffuse parenchymal dysfunction in pediatric patients with HIVN. Such dysfunction may provide corroborative evidence of HIVN and should be recognized when the test is performed for standard indications. Further work is necessary to prove that the test has indeed the high sensitivity and good correlation with the severity of HIVN suggested in this population; the test may be useful to follow up the progression of disease and the effect of treatment.",
keywords = "Tc-mercaptoacetyltriglycine, AIDS, HIV nephropathy, Pediatrics, Scintirenography",
author = "Sfakianakis, {George N} and Carmona, {Antonio J.} and Amita Sharma and Jose Strauss and Mike Georgiou and Zilleruelo, {Gaston E} and Carolyn Abitbol and Montane, {Brenda S.}",
year = "2000",
month = "6",
day = "1",
language = "English",
volume = "41",
pages = "1037--1042",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "6",

}

TY - JOUR

T1 - Diuretic MAG3 scintirenography in children with HIV nephropathy

T2 - Diffuse parenchymal dysfunction

AU - Sfakianakis, George N

AU - Carmona, Antonio J.

AU - Sharma, Amita

AU - Strauss, Jose

AU - Georgiou, Mike

AU - Zilleruelo, Gaston E

AU - Abitbol, Carolyn

AU - Montane, Brenda S.

PY - 2000/6/1

Y1 - 2000/6/1

N2 - HIV nephropathy (HIVN) is prevalent in 15%-56% of HIV-infected children and induces mild to severe progressive nephropathy. Methods: A total of 33 renal diuretic scintirenographic studies with 99mTc- mercaptoacetyltriglycine (MAG3) were reviewed and analyzed from 23 HIV pediatric patients, 21 of whom had HIVN with varying degrees of renal impairment. Results were compared with 10 studies of control patients of matching ages. Visual interpretation of images and renograms as well as semiquatitative analyses were performed. Variables compared were size of kidneys, time of peak and one-half peak activities, residual (or retained) cortical activity at 20 min, ratio of cortical activity at 2.5-20 min, and ratio of kidney activity to kidney plus background activity at 2 min. The results of MAG3 renal studies were also compared with laboratory data pertaining to creatinine clearance in all patients and with sonography in 17 patients. Results: In most patients with HIVN (18/21), the kidneys were larger than normal, with a diffuse parenchymal dysfunction (decreased uptake, slow processing, and increased retention of activity) and flat renograms, findings similar to those observed in other diffuse parenchymal diseases. In all patients with HIVN, semiquantitative analysis (paired t test) showed statistical significant differences from control patients for all variables. On ANOVA, a statistically significant correlation was found between most scintigraphic parameters and the severity of renal impairment. Of the 17 concurrent sonographic studies in HIVN patients, 7 showed no abnormalities, whereas the results of scintigraphy were abnormal. Conclusion: Diuretic MAG3 scintirenography shows nonspecific diffuse parenchymal dysfunction in pediatric patients with HIVN. Such dysfunction may provide corroborative evidence of HIVN and should be recognized when the test is performed for standard indications. Further work is necessary to prove that the test has indeed the high sensitivity and good correlation with the severity of HIVN suggested in this population; the test may be useful to follow up the progression of disease and the effect of treatment.

AB - HIV nephropathy (HIVN) is prevalent in 15%-56% of HIV-infected children and induces mild to severe progressive nephropathy. Methods: A total of 33 renal diuretic scintirenographic studies with 99mTc- mercaptoacetyltriglycine (MAG3) were reviewed and analyzed from 23 HIV pediatric patients, 21 of whom had HIVN with varying degrees of renal impairment. Results were compared with 10 studies of control patients of matching ages. Visual interpretation of images and renograms as well as semiquatitative analyses were performed. Variables compared were size of kidneys, time of peak and one-half peak activities, residual (or retained) cortical activity at 20 min, ratio of cortical activity at 2.5-20 min, and ratio of kidney activity to kidney plus background activity at 2 min. The results of MAG3 renal studies were also compared with laboratory data pertaining to creatinine clearance in all patients and with sonography in 17 patients. Results: In most patients with HIVN (18/21), the kidneys were larger than normal, with a diffuse parenchymal dysfunction (decreased uptake, slow processing, and increased retention of activity) and flat renograms, findings similar to those observed in other diffuse parenchymal diseases. In all patients with HIVN, semiquantitative analysis (paired t test) showed statistical significant differences from control patients for all variables. On ANOVA, a statistically significant correlation was found between most scintigraphic parameters and the severity of renal impairment. Of the 17 concurrent sonographic studies in HIVN patients, 7 showed no abnormalities, whereas the results of scintigraphy were abnormal. Conclusion: Diuretic MAG3 scintirenography shows nonspecific diffuse parenchymal dysfunction in pediatric patients with HIVN. Such dysfunction may provide corroborative evidence of HIVN and should be recognized when the test is performed for standard indications. Further work is necessary to prove that the test has indeed the high sensitivity and good correlation with the severity of HIVN suggested in this population; the test may be useful to follow up the progression of disease and the effect of treatment.

KW - Tc-mercaptoacetyltriglycine

KW - AIDS

KW - HIV nephropathy

KW - Pediatrics

KW - Scintirenography

UR - http://www.scopus.com/inward/record.url?scp=0034050003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034050003&partnerID=8YFLogxK

M3 - Article

C2 - 10855631

AN - SCOPUS:0034050003

VL - 41

SP - 1037

EP - 1042

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 6

ER -